retatrutide dosing clinical trial retatrutide dose Breaking: New data just released. TRIUMPH-1 study results on the triple agonist. Eli Lilly's trial on (triple agonist compound). 80 weeks. Phase 3 data. The results: At 12mg Retatrutide Dosing Schedule: Proven 2026
Pay in 4 interest-free payments of $7.09 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26

























